EF17 image

Hot Topics in Psoriatic Arthritis

In the Pipeline

In an interview, M. Elaine Husni, MD, MPH, of Cleveland Clinic, said she was excited for new oral JAK inhibitors coming down the pipeline, which show promising early clinical data.

References: